Recombinant zebrafish SND1 fragments are primarily used for:
Antibody Validation: Polyclonal antibodies targeting human SND1 (e.g., AA 560–732) show cross-reactivity with zebrafish SND1, enabling immunological studies .
Structural Biology: Partial proteins (e.g., SN1–SN4 or Tudor-SN5) are used to study RNA-binding specificity or enzymatic cleavage of mismatched RNAs .
Cancer Research: Overexpression of SND1 correlates with metastasis in mammals; zebrafish models may elucidate conserved oncogenic pathways .
Limited Zebrafish-Specific Data: Most functional insights derive from mammalian or C. elegans studies .
Domain-Specific Activity: Partial recombinants may lack full enzymatic or interaction capabilities compared to full-length proteins .
The following table highlights structural and functional conservation between zebrafish and human SND1:
Structural Characterization: High-resolution crystallography of zebrafish SND1 domains is needed to confirm RNA-binding motifs.
Functional Validation: Knockout/knockdown studies in zebrafish embryos could clarify roles in development and disease.
Therapeutic Potential: Testing SND1 inhibitors in zebrafish cancer models may validate conserved targets for oncology .
Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this in your order notes; we will fulfill your request to the best of our ability.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
The tag type will be determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
SND1 (staphylococcal nuclease and Tudor domain containing 1) protein is an evolutionarily conserved protein approximately 100 kDa in size. The protein structure typically consists of four tandem repeats of staphylococcal nuclease-like domains at the N-terminus and a TSN domain embedded with Tudor at the C-terminus . In zebrafish, as in other vertebrates, this structural arrangement is preserved, reflecting the high degree of conservation across species including human, mouse, rat, cow, and zebrafish . The conservation of these domains suggests critical functional importance across evolutionary history.
SND1 demonstrates remarkable versatility in its cellular distribution. While traditionally considered a nuclear and cytoplasmic protein, research has revealed that SND1 can also localize to mitochondria . The N-terminal region (specifically amino acids 1-63 in human SND1) serves as a mitochondrial targeting sequence (MTS), with the translocase of outer membrane 70 (TOM 70) facilitating mitochondrial import . In stressful conditions like FCCP treatment or glucose deprivation, SND1 accumulation in mitochondria increases, suggesting stress-responsive relocalization . Although this has been primarily demonstrated in mammalian cells, the evolutionary conservation of SND1 suggests similar localization patterns may exist in zebrafish cells.
While specific developmental expression patterns in zebrafish aren't explicitly detailed in the search results, SND1's evolutionary conservation suggests important developmental roles. By analogy with other systems, SND1 likely shows tissue-specific and temporally regulated expression during zebrafish embryogenesis and organogenesis. In other organisms, SND1 variants have been identified with tissue-specific functions, such as the stem-differentiating xylem (SDX)-specific alternative splice variant in poplar trees . Similar developmental and tissue-specific expression patterns may exist in zebrafish, particularly in tissues undergoing active differentiation and remodeling.
Recombinant zebrafish SND1 expression requires careful optimization of several parameters:
Expression System Selection:
Bacterial systems (E. coli BL21 or Rosetta strains) work well for partial domains but may struggle with full-length SND1 due to size and post-translational modifications
Eukaryotic systems like insect cells (Sf9, High Five) or mammalian cells (HEK293, CHO) offer better folding and modifications for full-length protein
Expression Optimization:
Temperature: Lower temperatures (16-18°C) typically improve solubility
Induction: For IPTG-inducible systems, concentrations of 0.1-0.5 mM and induction at OD600 0.6-0.8
Co-expression with chaperones may improve folding
Purification Strategy:
Affinity chromatography using His-tag, GST-tag, or MBP-tag as initial capture
Ion exchange chromatography for intermediate purification
Size exclusion chromatography for final polishing and buffer exchange
Buffer Considerations:
Phosphate or Tris buffers (pH 7.4-8.0)
Salt concentration: 150-300 mM NaCl
Glycerol (5-10%) for stability
Reducing agents like DTT or β-mercaptoethanol (1-5 mM)
Protease inhibitors during initial extraction
The multidomain architecture of SND1 may require domain-specific expression strategies if the full-length protein proves challenging to produce.
SND1's role as an RNA-binding protein can be investigated through multiple complementary approaches:
In Vitro RNA-Binding Assays:
RNA electrophoretic mobility shift assays (EMSA) using purified recombinant SND1 and synthetic RNA oligos
RNA pull-down assays with biotinylated RNA substrates
Surface plasmon resonance (SPR) or microscale thermophoresis for binding kinetics determination
Transcriptome-Wide Binding Analysis:
Modified RIP-seq (RNA immunoprecipitation sequencing) approaches can reveal the binding profile of SND1 to cellular RNAs
Enhanced crosslinking immunoprecipitation (eCLIP) analysis to identify binding sites with nucleotide resolution
PAR-CLIP (Photoactivatable Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation) to identify direct RNA-protein interactions
m6A-Methylated RNA Interactions:
Research has identified SND1 as an m6A RNA reader protein, capable of recognizing methylated RNA . Specific experiments to investigate this in zebrafish include:
Comparing binding affinities between methylated and unmethylated RNA substrates
m6A-seq to map methylation sites in zebrafish transcriptome
Functional assays to determine how methylation impacts SND1's regulatory functions
Functional Validation:
SND1 knockdown in zebrafish followed by RNA stability measurements
Reporter assays with wild-type and mutated RNA binding motifs
Investigating SND1 subcellular dynamics in zebrafish presents several technical challenges:
Live Imaging Limitations:
Limited optical transparency in adult zebrafish tissues restricts live imaging to embryonic stages or superficial adult tissues
Generation of fluorescently tagged SND1 that retains full functionality
Potential interference of tags with subcellular localization signals, particularly the mitochondrial targeting sequence
Antibody Specificity Issues:
Limited availability of zebrafish-specific SND1 antibodies
Cross-reactivity concerns with antibodies raised against mammalian orthologs
Distinguishing between splice variants and post-translationally modified forms
Mitochondrial Localization Studies:
Research has demonstrated that SND1 localizes to mitochondria through its N-terminal mitochondrial targeting sequence in mammalian cells . For zebrafish studies, researchers should:
Validate conservation of the mitochondrial targeting sequence in zebrafish SND1
Develop appropriate subcellular fractionation protocols for zebrafish tissues
Confirm mitochondrial import mechanisms via TOM complex proteins
Stress-Induced Relocalization:
Establishing appropriate stress conditions relevant to zebrafish physiology that trigger SND1 relocalization
Development of quantitative measurements for dynamic changes in localization
Correlation between relocalization and functional outcomes
Recent research has identified a critical role for SND1 in promoting PGAM5-mediated mitophagy in mammalian systems . Investigating this pathway in zebrafish requires comparative analysis:
Conservation Analysis:
Sequence alignment of zebrafish SND1 and PGAM5 with mammalian counterparts
Identification of conserved interaction domains and binding motifs
Phylogenetic analysis of pathway components across vertebrates
Interaction Validation:
Co-immunoprecipitation of zebrafish SND1 with PGAM5 from fish tissues or cells
Proximity ligation assays to visualize interactions in situ
Yeast two-hybrid or mammalian two-hybrid assays with zebrafish proteins
Functional Pathway Assessment:
Analysis of mitochondrial dynamics markers (DRP1, mitofusins) and their relation to SND1
Mitophagy flux measurements using mitochondrial reporters in zebrafish cells
FCCP-induced or glucose deprivation stress responses and SND1's role therein
Comparative Outcomes:
Side-by-side comparison of mitophagy parameters in zebrafish versus mammalian cells
Analysis of tissue-specific variations in pathway activity
Evolutionary adaptation differences in mitophagy regulation
Selecting appropriate zebrafish models depends on research objectives and specific SND1 functions under investigation:
Genetic Knockdown/Knockout Approaches:
Morpholino antisense oligonucleotides for transient knockdown in embryos
CRISPR/Cas9-mediated knockout for permanent genetic modification
Conditional knockout systems (e.g., Cre/loxP) for tissue-specific or temporal control
Transgenic Reporter Lines:
SND1 promoter-driven fluorescent reporters to visualize expression patterns
Fluorescently-tagged SND1 to monitor subcellular localization
Split reporter systems for detecting protein-protein interactions in vivo
Disease Models:
Liver cancer models to study SND1's role in hepatocellular carcinoma progression
Inflammation models to assess SND1's role in inflammatory processes
Mitochondrial stress models to investigate SND1's role in mitophagy
Cell Line Options:
ZF4 or PAC2 zebrafish fibroblast cell lines for in vitro studies
Primary cell cultures from relevant zebrafish tissues
Development of stable cell lines with modified SND1 expression
SND1 splice variants may have significant functional implications, as demonstrated in other systems . Effective analysis requires:
Identification Methods:
RNA-Seq analysis with appropriate read depth and coverage
RT-PCR with primers spanning potential splice junctions
Rapid Amplification of cDNA Ends (RACE) to identify novel 5' and 3' variants
Functional Characterization:
Expression pattern analysis of different variants across tissues and developmental stages
Subcellular localization studies for each variant
Domain analysis to predict functional differences
Regulatory Mechanisms:
Analysis of splice site selection factors
Investigation of stress-induced alternative splicing
Epigenetic influences on splice variant expression
Comparing Splice Variant Functions:
Research in poplar has identified a splice variant (PtrSND1-A2(IR)) that acts as a dominant negative regulator of SND1 transcriptional activity . Similar regulatory mechanisms may exist in zebrafish, requiring:
Comparative analysis of transcriptional activity between variants
Assessment of DNA binding capabilities
Evaluation of dimerization potential and protein-protein interactions
Nuclear translocation studies to determine localization differences between variants
SND1 has been implicated in various diseases, particularly cancer . To study its role in zebrafish disease models:
Cancer Models:
Chemically-induced liver cancer models (e.g., diethylnitrosamine)
Genetic cancer models with common oncogenic drivers
Xenograft approaches for studying human cancer cells in zebrafish embryos
Experimental Designs:
Rescue experiments with wild-type or mutant SND1 in knockout backgrounds
Pharmacological modulation of SND1-regulated pathways
Combination approaches targeting multiple components of SND1 pathways
Phenotypic Assessments:
Survival analysis
Tumor growth and metastasis quantification
Histopathological examination of affected tissues
Molecular Analyses:
Transcriptomic profiling to identify SND1-dependent gene expression changes
Proteomic analysis to identify altered protein interactions
Metabolomic analysis to identify downstream metabolic effects
Comparative studies provide valuable evolutionary insights and potential translation of findings:
Sequence and Structure Analysis:
Multiple sequence alignment of SND1 proteins across species
Structure prediction and comparison of functional domains
Analysis of conservation in key regions (e.g., the mitochondrial targeting sequence )
Functional Conservation Testing:
Cross-species rescue experiments
Domain swapping between zebrafish and mammalian SND1
Binding partner identification and comparison
Expression Systems:
Parallel expression studies in zebrafish and mammalian cell lines
Comparison of post-translational modifications
Subcellular localization patterns across species
Disease Model Relevance:
How well zebrafish models recapitulate human SND1-associated diseases
Species-specific differences in SND1 regulation and function
Translatability of zebrafish findings to mammalian systems